Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02353221 · ClinicalTrials.gov registry record
CPMC Early Undifferentiated Arthritis Registry
A clinical trial, sponsored by California Pacific Medical Center Research Institute.
- Completed
- Registry status
- 54
- Enrollment target
NCT02353221 is a clinical trial that has completed, run by California Pacific Medical Center Research Institute. The registered enrollment target is 54 participants.
The verdict
NCT02353221 has completed, sponsored by California Pacific Medical Center Research Institute.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The CPMC early arthritis registry will recruit participants from a population of new patients undergoing evaluation at the office of participating physicians. Patients enrolled in the registry will undergo longitudinal observation and sampling. The investigators will collect questionnaire data and create a biological sample repository. The information obtained will be use to generate hypotheses aimed at explaining how environmental and genetic factors are interrelated to influence UA disease outcomes. Analysis will be performed on the patient's data and biological samples in order to; A. Assess the epidemiological and clinical characteristics of patients with early arthritis in the referral pool at CPMC. B. Analyze the phenotype and genotype of peripheral blood mononuclear cells (PBMC) from individual patients based on their chemokine/cytokine secretion, cell adhesion molecule expression, gene expression, DNA methylation and non coding RNA profiles. C. Generate hypothesis aimed to identify clinical criteria and novel biomarkers to be used in the diagnosis, prognosis, and therapeutic decisions for patients with early UA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-01 |
| Est. Completion | 2022-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02353221
The ClinicalTrials.gov registry entry for NCT02353221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Pacific Medical Center Research Institute, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02353221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02353221 about?
NCT02353221 is a clinical study titled "CPMC Early Undifferentiated Arthritis Registry". The CPMC early arthritis registry will recruit participants from a population of new patients undergoing evaluation at the office of participating physicians. Patients enrolled in the registry will undergo longitudinal observation and sampling. The investigators will collect questionnaire data and c...
What is the current status of trial NCT02353221?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2015-01. Estimated completion is 2022-01.
Who is sponsoring clinical trial NCT02353221?
This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.